ID

34475

Beschreibung

Preoperative Magnetic Resonance (MR) Imaging of Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01347320

Link

https://clinicaltrials.gov/show/NCT01347320

Stichworte

  1. 17.01.19 17.01.19 -
  2. 27.05.19 27.05.19 -
  3. 29.05.19 29.05.19 - Sarah Riepenhausen
Rechteinhaber

see on clinicaltrials.gov

Hochgeladen am

17. Januar 2019

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Prostate Cancer NCT01347320

Eligibility Prostate Cancer NCT01347320

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
all patients suitable for surgery.
Beschreibung

ID.1

Datentyp

boolean

positive biopsy (gleason grade >3).
Beschreibung

ID.2

Datentyp

boolean

informed consent.
Beschreibung

ID.3

Datentyp

boolean

Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients who do not sign the consent paper for any reason or do not accept the study premises.
Beschreibung

ID.4

Datentyp

boolean

patents who want to withdraw for any reason during the study.
Beschreibung

ID.5

Datentyp

boolean

patients with contraindications to mri (pacemaker, claustrophobia etc) and/or surgery.
Beschreibung

ID.6

Datentyp

boolean

patients who have undergone a high quality mri examination of the prostate at another radiological center. in this situation the mr examination is evaluated together with the surgeon but the patient is not included in the study. (in case of a low quality examinations, we will disregard the findings, and include the patient).
Beschreibung

ID.7

Datentyp

boolean

if the surgeon finds it unacceptable to perform ralp without mri, because of various reasons (eg. patient demand, too high risk etc) the patient will not be included in the study.
Beschreibung

ID.8

Datentyp

boolean

if preoperative mri reveals extensive tumor invasion into adjacent organ (t4) or skeletal metastases (m1), as these cancer stadiums do not benefit from ralp.
Beschreibung

ID.9

Datentyp

boolean

Ähnliche Modelle

Eligibility Prostate Cancer NCT01347320

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
all patients suitable for surgery.
boolean
ID.2
Item
positive biopsy (gleason grade >3).
boolean
ID.3
Item
informed consent.
boolean
Item Group
C0680251 (UMLS CUI)
ID.4
Item
patients who do not sign the consent paper for any reason or do not accept the study premises.
boolean
ID.5
Item
patents who want to withdraw for any reason during the study.
boolean
ID.6
Item
patients with contraindications to mri (pacemaker, claustrophobia etc) and/or surgery.
boolean
ID.7
Item
patients who have undergone a high quality mri examination of the prostate at another radiological center. in this situation the mr examination is evaluated together with the surgeon but the patient is not included in the study. (in case of a low quality examinations, we will disregard the findings, and include the patient).
boolean
ID.8
Item
if the surgeon finds it unacceptable to perform ralp without mri, because of various reasons (eg. patient demand, too high risk etc) the patient will not be included in the study.
boolean
ID.9
Item
if preoperative mri reveals extensive tumor invasion into adjacent organ (t4) or skeletal metastases (m1), as these cancer stadiums do not benefit from ralp.
boolean

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video